Abstract
Inflammatory bowel diseases (IBDs), including Crohn’s disease and ulcerative colitis, involve an interplay between host genetics and environmental factors including intestinal microbiota. Animal models of IBD have indicated that chronic inflammation can result from over-production of inflammatory responses or deficiencies in key negative regulatory pathways. Recent research advances in both T-helper 1 (Th1) and T-helper 17 (Th17) effect responses have offered new insights on the induction and regulation of mucosal immunity which is linked to the development of IBD. Th17 cytokines, such as IL-17 and IL-22, in combination with IL-23, play crucial roles in intestinal protection and homeostasis. IL-23 is expressed in gut mucosa and tends to orchestrate T-cell-independent pathways of intestinal inflammation as well as T cell dependent pathways mediated by cytokines produced by Th1 and Th17 cells. Th17 cells, generally found to be proinflammatory, have specific functions in host defense against infection by recruiting neutrophils and macrophages to infected tissues. Here we will review emerging data on those cytokines and their related regulatory networks that appear to govern the complex development of chronic intestinal inflammation; we will focus on how IL-23 and Th17 cytokines act coordinately to influence the balance between tolerance and immunity in the intestine.
Similar content being viewed by others
References
Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427–434
Elson CO, Cong Y, Weaver CT et al (2007) Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132:2359–2370
Hue S, Ahern P, Buonocore S et al (2006) Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 203:2473–2483
Uhlig HH, McKenzie BS, Hue S et al (2006) Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25:309–318
Yen D, Cheung J, Scheerens H et al (2006) IL-23 is essential for T cell mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116:1310–1316
Duerr RH, Taylor KD, Brant SR et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461–1463
Wilson NJ, Boniface K, Chan JR et al (2007) Cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8:950–957
Veldhoen M, Hocking RJ, Atkins CJ et al (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24(2):179–189
Veldhoen M, Hocking RJ, Flavell RA et al (2006) Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 7:1151–1156
Volpe E, Servant N, Zollinger R et al (2008) Critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 9:650–657
Izcue A, Coombes JL, Powrie F (2006) Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 212:256–271
Abreu MT, Fukata M, Arditi M (2005) TLR signalingin the gut in health and disease. J Immunol 174:4453–4460
Hamada H, Hiroi T, Nishiyama Y et al (2002) Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J Immunol 168:57–64
Newberry RD, Lorenz RG (2005) Organizing a mucosal defense. Immunol Rev 206:6–21
Oppmann B, Lesley R, Blom B et al (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715–725
Ahern PP, Izcue A, Maloy KJ et al (2008) The interleukin-23 axis in intestinal inflammation. Immunol Rev 226:147–159
Parham C, Chirica M, Timans J et al (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168:5699–5708
Kullberg MC, Jankovic D, Feng CG et al (2006) IL-23 plays a key role in Helicobacter hepaticus-induced T celldependent colitis. J Exp Med 203:2485–2494
Becker C, Dornhoff H, Neufert C et al (2006) IL-23 Cross-Regulates IL-12 Production in T Cell-Dependent Experimental Colitis. J Immunol 177:2760–2764
Dong C (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8:337–348
Nurieva R, Yang XO, Martinez G et al (2007) Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448:480–483
Zhou L, Ivanov II, Spolski R et al (2007) IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8:967–974
Williams IR (2006) CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis. Ann NY Acad Sci 1072:52–61
Fort MM, Cheung J, Yen D et al (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15:985–995
Yao Z, Fanslow WC, Seldin MF et al (1995) Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3:811–821
Toy D, Kugler D, Wolfson M et al (2006) Cutting edge: Interleukin-17 signals through a heteromeric receptor complex. J Immunol 177:36–39
Park H, Li Z, Yang XO et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin-17. Nat Immunol 6:1133–1141
Reiko I, Masakazu K, Masaharu S et al (2008) Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice Biochem. Biophys Res Commun 377:12–16
Zhang Z, Zheng M, Bindas J et al (2006) Critical role of IL-17 receptor signaling in acute TNBS-induced colitis, Inflamm. Bowel Dis 12:382–388
O’Connor W Jr, Kamanaka M, Booth CJ et al (2009) A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 10:603–609
Ogawa A, Andoh A, Araki Y et al (2004) Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 110:55–62
Langrish CL, Chen Y, Blumenschein WM et al (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233–240
Chang SH, Dong C (2007) A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Cell Res 17:435–440
Kuestner RE, Taft DW, Haran A et al (2007) Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J Immunol 179:5462–5473
Wolk X, Kunz S, Witte E et al (2004) IL-22 increases the innate immunity of tissues. Immunity 21:241–254
Zheng Y, Danilenko DM, Valdez P et al (2007) Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445:648–651
Kreymborg K, Etzensperger R, Dumoutier L et al (2007) IL-22 is expressed by TH17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J Immunol 179:8098–8104
Sugimoto X, Ogawa A, Mizoguchi E et al (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118:534–544
Zheng X, Valdez PA, Danilenko DM et al (2008) Interleukin 22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14:282–289
Sanos X, Bui VL, Mortha A et al (2009) RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 10:83–91
Malmberg K, Ljunggren H (2009) Spotlight on IL-22-producing NK cell receptor expressing mucosal lymphocytes. Nat Immunol 10:11–12
Izcue A, Hue S, Buonocore S et al (2008) Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 28:559–570
Sutton C, Brereton C, Keogh B et al (2006) A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 203:1685–1691
Yang XO, Chang SH, Park H et al (2008) Regulation of inflammatory responses by IL-17F. J Exp Med 205:1063–1075
Korn T, Bettelli E, Gao W et al (2007) IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448:484–487
Chen Z, Laurence A, Kanno Y et al (2006) Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci USA 103:8137–8142
Ivanov II, McKenzie BS, Zhou L et al (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121–1133
Zhou L, Lopes JE, Chong MM et al (2008) TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453:236–240
Author information
Authors and Affiliations
Corresponding author
Additional information
Special issue article in honor of Professor Armen Galoyan.
Rights and permissions
About this article
Cite this article
Shen, W., Durum, S.K. Synergy of IL-23 and Th17 Cytokines: New Light on Inflammatory Bowel Disease. Neurochem Res 35, 940–946 (2010). https://doi.org/10.1007/s11064-009-0091-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-009-0091-9